Novartis UK has been recognized for its “people-first” human resources (HR) practices by being officially certified as a 2019 Top Employer by the Top Employers Institute, the sixth consecutive year the company has been granted this status. Sandoz UK, a division of the Novartis Group, has also been certified as a 2019 Top Employer. The annual, international Top Employer award recognizes market-leading employers that provide exceptional employee conditions. Contributing to Novartis UK’s success this year was the launch of three new wellbeing initiatives: • the Ensemble program, which supports Novartis associates in the UK whose lives have been affected by cancer, whether they are facing cancer as an individual, caregiver or as a manager; • a mental health action plan, put in place across Novartis UK to break the stigma about mental health in the workplace; • the Energized for Life program, which encourages all Novartis employees to realize their full potential and be their “best self every day and everywhere”. The program concentrates on a new cultural aspiration to be inspired, curious and “unbossed”. Erica Cassin, HR Director at Novartis UK, commented: “This year we have placed huge focus on our employee wellbeing offering through the launch of UK-specific support hubs for associates affected by mental health challenges and cancer. I am extremely proud that these important initiatives have contributed to our Top Employer success, and that they help to ensure Novartis remains an employer of choice.” www.top-employers.com
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.